A study evaluates the feasibility and clinical utility of integrating routine, electronic patient-reported outcome screening into a dedicated thyroid cancer survivorship clinic to monitor long-term ...

Researchers investigated inotuzumab ozogamicin for children with CD22-positive, very high-risk first B-cell acute lymphoblastic leukemia relapse.

Investigators evaluated the relationship between overall survival and discontinuing immune checkpoint inhibitor therapy due to immunological toxicity in patients with metastatic melanoma.

Emergency presentation (EP) for cancer diagnosis is common among older U.S. adults and predicts persistently elevated mortality, according to a study published ...